시장보고서
상품코드
1172471

세계의 고인혈증 치료제 시장 : 제품 유형별, 유통 채널별, 지역별 - 예측 및 분석(2022-2028년)

Global Hyperphosphatemia Therapeutics Market, By Product Type, By Distribution Channel & By Region- Forecast and Analysis 2022-2028

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 고인혈증 치료제 시장 규모는 2021년 24억 6,000만 달러에서 2028년 35억 3,000만 달러에 이를 것으로 예상되며, 2022년부터 2028년까지 CAGR 5.3%를 나타낼 것으로 예측됩니다. 말기 신부전 발생률 증가, 치료를 포함한 집학적 접근으로 관리할 필요성 증가는 시장 성장을 촉진하고 있습니다.

세계의 고인혈증 치료제(Hyperphosphatemia Therapeutics) 시장에 대해 조사 분석하여 시장 주요 요약, 시장 규모, 시장 역학, 기업 프로필 등 체계적인 정보를 제공합니다.

목차

주요 요약

시장 주요 요약

  • 자료 : 주요 요약-시장 주요 요약 그림
  • 자료 : 주요 요약-시장 주요 요약 데이터 표
  • 자료 : 주요 요약-세계의 고인혈증 치료제 시장 특징에 관한 그림
  • 자료 : 주요 요약-시장 지역 : 지역별
  • 자료 : 주요 요약-시장 세분화 그림
  • 자료 : 주요 요약-증분 성장 그림
  • 자료 : 주요 요약-증분 성장에 관한 데이터표
  • 자료 : 주요 요약-벤더 시장 포지셔닝에 관한 그림

상위 시장 분석

시장 주요 요약

시장 규모

  • 시장 역학
    • 자료:DROC 영향 분석(2021년)
  • 촉진 요인
  • 기회
  • 억제 요인
  • 과제
  • SWOT 분석

주요 시장 전망

  • 기술분석
    • (자료:데이터표:기술명과 상세)
  • 가격 분석
    • (자료:데이터표:기술명과 가격 상세)
  • 공급망 분석
    • (자료:자세한 공급 체인 프레젠테이션)
  • 밸류체인 분석
    • (자료:자세한 밸류체인 프레젠테이션)
  • 시장 생태계
    • 자료 : 부모 시장 생태계 시장 분석
    • 도표 : 부모 시장 시장 특징
  • IP 분석
    • (자료 : 데이터표 : 제품·기술명, 출원 특허, 발명자·기업명, 취득 기업)
  • 무역 분석
    • (자료:데이터표:수출입 데이터 상세)
  • 스타트업 분석
    • (자료:데이터표:신흥 스타트업 상세)
  • 원재료 분석
    • (자료 : 데이터표 : 주요 원재료 매핑)
  • 혁신 매트릭스
    • (자료:포지셔닝 매트릭스:신기술과 기존 기술 매핑)
  • 파이프라인 제품 분석
    • (자료:데이터표:기업명과 파이프라인 제품, 지역별 매핑)
  • 거시경제지표

신종 코로나바이러스 영향

  • 소개
  • 경제 시나리오 평가에 미치는 영향
    • 자료:GDP에 관한 데이터-전년대비 성장률(%)(2016-2022년)
  • 수정된 시장 규모
    • 자료 고인혈증 치료제 시장 규모와 예측 데이터표(100만 달러)(2022-2028년)
  • COVID가 주요 부문에 미치는 영향
    • 자료 : 부문 시장 규모와 예측 데이터표(100만 달러)(2022-2028년)
  • COVID 전략 : 기업별
    • 자료 : 기업이 채용하는 주요 전략에 관한 분석

시장 역학과 전망

  • 시장 역학
    • 자료:DROC 영향 분석(2021년)
  • 촉진 요인
  • 기회
  • 억제 요인
  • 과제
  • 규제 상황
    • 자료 : 다른 지역 규제에 관한 데이터표
  • SWOT 분석
  • 포터의 분석
    • 경쟁 기업 간 적대 관계
  • 도표 : 경쟁기업간 적대관계, 주요 요인 영향(2021년)
    • 대체품 위협
  • 도표 : 대체 제품 위협과 주요 요인 영향(2021년)
    • 구매자 협상력
  • 도표 : 구매자 협상력 주요 요인 영향(2021년)
    • 신규 참가업체 위협
  • 도표 : 신규 참가자 위협 주요 요인 영향(2021년)
    • 공급기업 협상력
  • 도표 : 공급업체 협상력 위협 주요 요인 영향(2021년)
  • 미래 혼란에 관한 스카이퀘스트 특별한 통찰
    • 정치적 영향
    • 경제적 영향
    • 사회적 영향
    • 기술적 영향
    • 환경적 영향
    • 법적 영향
  • 세계의 고인혈증 치료제 시장 :제품 유형별
  • 시장 내역
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료 : 시장 점유율 데이터표(%)(2022-2028년)
  • 세베라머
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 칼슘계 인산염 브라인더
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 철계 인산 결합제
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 탄산란탄
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 비인산 결합제
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 기타
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 세계의 고인혈증 치료제 시장 : 유통 채널별
  • 시장 내역
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료 : 시장 점유율 데이터표(%)(2022-2028년)
  • 병원 약국
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 소매 약국
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)
  • 온라인 약국
    • 시장 추정·예측(2022-2028년)
  • 자료:시장 점유율(%)(2022-2028년)
  • 자료:시장 규모와 예측(100만 달러)(2022-2028년)

시장 규모 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양 지역
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양 지역
  • 라틴아메리카
    • 브라질
    • 그 외 남미
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카
    • 기타 중동 및 아프리카

주요 기업 프로필

  • 경쟁 상황
  • 첨부 자료:조사 대상 기업(2021년)
  • 첨부 자료 : 기업 포지셔닝 매트릭스(2021년)
  • 첨부 자료 : 기업 시장 점유율, 원 그래프 분석(%)(2021년)
NJH 22.12.28

Global Hyperphosphatemia Therapeutics Market was valued at USD 2.46 billion in 2021,and it is expected to reach USD 3.53 billion by 2028 at a CAGR of 5.3 % over the forecast period (2022-2028).

A condition called hyperphosphatemia is brought on by a high level of phosphate or phosphorous in the blood. The chemical phosphate, which contains the mineral phosphorous, is present in the body. The mineral phosphorus is crucial for the growth of teeth and bones as well as for converting food into body energy. The main locations of phosphate in the body are the teeth, bones, cells, and in very small quantities, the blood. The kidneys have a role in controlling the body's phosphate levels. However, a variety of issues or illnesses cause kidney damage, which results in a persistently high level of phosphate in the blood. People with end-stage kidney disease are more likely to develop hyperphosphatemia, which is very common in people with chronic kidney disease.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyperphosphatemia Therapeutics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. 

Segments covered in this report:

Global Hyperphosphatemia Therapeutics Market is segmented by Product Type, Distribution Channel, and Region. Based on Product Type, the market is segmented into Sevelamer, Calcium-based Phosphate Blinders, Iron-based Phosphate Binders, Lanthanum Carbonate, Non-phosphate Binders, and Others. Based on Distribution channels, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on region, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

An important driver that is enhancing the prospects for new pharmaceutical interventions in the market for treating hyperphosphatemia is the increasing incidence of end-stage renal disease. The available management options suggest using an integrated strategy to lower high levels of calcium and phosphorus. The patient population's high risk of cardiovascular events has increased the need for a multidisciplinary approach to managing it, including treatment. The market for treating hyperphosphatemia appears to have an unmet need for products combining calcium acetate and magnesium. The new class of phosphate binders is of particular interest. Clinical trials that specifically focus on evaluating them for their effectiveness, tolerability, and safety in advanced chronic kidney disease are therefore urgently needed (CKD).

Restraint

One of the main factors limiting the market's growth is poor treatment compliance among dialysis patients as a result of their heavy pill load. For instance, a dialysis patient is typically expected to take 10 to 12 different types of medications, according to a National Center for Biotechnology Information (NCBI) article. Nearly 80% of patients take four or more pills daily from phosphate binders, which can have negative side effects like gastrointestinal intolerance. Therefore, it is anticipated that these factors will limit the uptake of phosphate binders among CKD patients, thereby limiting the market's expansion.

Market Trends

It is very difficult to achieve ideal phosphate control in CKD patients receiving dialysis. The ability to control phosphate levels in dialysis patients has not significantly improved despite the extraordinary advancements in dialysis techniques over the years. Phosphate binders also have a number of negative side effects. Researchers are therefore concentrating on the introduction of new hyperphosphatemia therapeutics and updating the treatment guidelines in order to improve the treatment option for hyperphosphatemia. Phosphate binders are expected to be replaced by non-phosphate binders in the treatment of hyperphosphatemia, such as Tenapanor, an inhibitor of the hydrogen/sodium exchanger isoform 3 (NHE3), which is currently being researched. By 2021, the drug is expected to go on sale.

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Global Hyperphosphatemia Therapeutics Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Global Hyperphosphatemia Therapeutics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Global Hyperphosphatemia Therapeutics Market by Product Type

  • Market segments
    • Exhibit: Chart on Market share 2021-2027 (%)
    • Exhibit: Data table on Market share 2021-2027 (%)
  • Sevelamer
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Calcium-based Phosphate Blinders
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Iron-based Phosphate Binders
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Lanthanum Carbonate
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Non-phosphate Binders
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Others
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

Global Global Hyperphosphatemia Therapeutics Market by Distribution Channel

  • Market segments
    • Exhibit: Chart on Market share 2021-2027 (%)
    • Exhibit: Data table on Market share 2021-2027 (%)
  • Hospital Pharmacies
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Retail Pharmacies
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Online Pharmacies
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제